---
$id: https://graph.org.ai/products/commodity/51241138
$type: Product
source: UNSPSC
code: "51241138"
title: "Cyclopentolate"
class: "51241100"
classTitle: "Ophthalmic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cyclopentolate

**UNSPSC Code**: 51241138
**Class**: [Ophthalmic agents](Ophthalmic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a mydriatic agent and antimuscarinic agent with the molecular formula C17H25NO3, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier I76F4SHP7J, chemically known as benzeneacetic acid, alpha-(1-hydroxycyclopentyl)-, 2-(dimethylamino)ethyl ester but more generally known as cyclopentolate, which bears U.S. NIH Compound Identifier 2905. European Medicines Agency schedules Cyclopentolate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06858MIG. The term CYCLOPENTOLATE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules cyclopentolate in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary. CYCLOPENTOLATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

